Improved Monitoring and Prediction of Clinical Response and Disease Course During Golimumab Therapy of Patients With Axial Spondyloarthritis

Trial Profile

Improved Monitoring and Prediction of Clinical Response and Disease Course During Golimumab Therapy of Patients With Axial Spondyloarthritis

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2013

At a glance

  • Drugs Golimumab (Primary)
  • Indications Spondylarthritis
  • Focus Therapeutic Use
  • Acronyms MANGO
  • Most Recent Events

    • 18 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top